Joseph Frattaroli

Net worth: 15 229 $ as of 2024-04-29

62 year

Health Technology

Consumer Services

Former positions of Joseph Frattaroli

Companies	Position	Start	End
INHIBIKASE THERAPEUTICS, INC.	Director of Finance/CFO	2018-03-31	2024-03-30
Vaso Active Pharmaceuticals, Inc. Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish.	Director of Finance/CFO	2009-12-23	2012-11-05
	President	2003-05-31	2012-11-05
Flagship Consulting, Inc.	Founder	2009-12-31	-

Salem State University

Undergraduate Degree

International

United States

Operational

Sectoral

Health Technology	3
Consumer Services	2

Positions held

Active

Inactive

Listed companies

Private companies

Listed companies	1
INHIBIKASE THERAPEUTICS, INC.	Health Technology

Private companies	2
Vaso Active Pharmaceuticals, Inc. Vaso Active Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Vaso Active Pharmaceuticals, Inc. develops, manufactures and markets pharmaceutical products. The Company focuses on vaso active lipid encapsulated or VALE, transdermal delivery technology drugs. Currently, they market Athlete's Relief and Osteon in the United States. The Company's products, include Analgesics, Toenail fungal treatment, Acne, First aid, Hand and body lotion and Psoriasis treatment. It is planning to rebrand the deFEET athlete's foot anti-fungal medication product as Termin8 and Xtinguish.	Health Technology
Flagship Consulting, Inc.

Private companies

Health Technology

Flagship Consulting, Inc.